[ACRX] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
06-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -19.29%
YoY- -48.97%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 407 940 1,675 166 224 329 624 -24.80%
PBT -17,447 -12,762 -33,363 -8,582 -6,596 -7,065 -20,101 -9.01%
Tax -9,273 -1,285 -22,841 390 248 519 -13,728 -23.03%
NP -17,447 -12,762 -10,522 -8,582 -7,194 -7,065 -6,372 95.83%
Tax Rate - - - - - - - -
Total Cost 17,854 13,702 12,197 8,748 7,418 7,394 6,996 86.85%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin -4,286.73 -1,357.66 -628.18 -5,169.88 -3,211.61 -2,147.42 -1,021.15 160.45%
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -9.36 -6.87 -5.67 -7.58 -6.98 -7.21 -6.50 27.54%
EPS Diluted -9.36 -6.87 -5.67 -7.58 -6.98 -7.21 -6.50 27.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.